{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:26:27Z","timestamp":1770823587772,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1053\/j.seminhematol.2011.03.006","type":"journal-article","created":{"date-parts":[[2011,7,25]],"date-time":"2011-07-25T03:35:06Z","timestamp":1311564906000},"page":"148-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Histopathology of Mantle Cell Lymphoma"],"prefix":"10.1053","volume":"48","author":[{"given":"Wolfram","family":"Klapper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2011.03.006_bib1","first-page":"405","article-title":"Classification of non-Hodgkin's lymphomas [letter]","volume":"2","author":"G\u00e9rard-Marchant","year":"1974","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","article-title":"Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network","volume":"131","author":"Tiemann","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib3","series-title":"WHO classification of tumors of the haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/cyto.b.20463","article-title":"Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: a case report","volume":"76","author":"Naushad","year":"2009","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib5","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/00000478-200608000-00004","article-title":"Mantle cell lymphoma with plasma cell differentiation","volume":"30","author":"Young","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2010-02-269514","article-title":"Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation","volume":"117","author":"Perez-Galan","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00428-005-0049-5","article-title":"Growth pattern and distribution of follicular dendritic cells in mantle cell lymphoma: a clinicopathological study of 96 patients","volume":"448","author":"Schrader","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib8","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0002-9440(10)65443-0","article-title":"Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas","volume":"154","author":"Fend","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2559.2007.02906.x","article-title":"In-situ mantle cell lymphoma\u2014a report of two cases","volume":"52","author":"Aqel","year":"2008","journal-title":"Histopathology"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib10","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/S0046-8177(03)00410-6","article-title":"Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes","volume":"34","author":"Nodit","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib11","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jcp.2005.030783","article-title":"\u201cIn situ-like\u201d mantle cell lymphoma: a report of two cases","volume":"59","author":"Richard","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib12","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood-2005-07-2845","article-title":"Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma","volume":"107","author":"Pott","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib13","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/cncr.22715","article-title":"Leukemic involvement is a common feature in mantle cell lymphoma","volume":"109","author":"Ferrer","year":"2007","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00292-006-0878-2","article-title":"[Follicular and mantle cell lymphoma: extranodal involvement of primarily nodal indolent B-cell lymphomas","volume":"28","author":"Klapper","year":"2006","journal-title":"Pathologe"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib15","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1038\/leu.2010.160","article-title":"Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping","volume":"24","author":"Costa","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib16","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1182\/blood-2008-08-175208","article-title":"Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance","volume":"113","author":"Hiraga","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib17","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/PAS.0b013e318054dbcf","article-title":"c-Maf expression in angioimmunoblastic T-cell lymphoma","volume":"31","author":"Murakami","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib18","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/modpathol.3880239","article-title":"Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia","volume":"13","author":"Miranda","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V99.3.815","article-title":"De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients","volume":"99","author":"Yamaguchi","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib21","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib22","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood-2007-06-093401","article-title":"Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma","volume":"111","author":"Ek","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib23","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/modpathol.2009.173","article-title":"Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes","volume":"23","author":"Metcalf","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib24","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3324\/haematol.2009.010173","article-title":"Differential diagnosis of cyclin D2+ mantle cell lymphoma based on fluorescence in situ hybridization and quantitative real-time-PCR","volume":"94","author":"Quintanilla-Martinez","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib25","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood-2006-01-0015","article-title":"A chromosomal translocation in cyclin D1-negative\/cyclin D2-positive mantle cell lymphoma fuses the CCND2 gene to the IGK locus","volume":"108","author":"Gesk","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib26","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1182\/blood-2002-01-0263","article-title":"Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis","volume":"101","author":"Quintanilla-Martinez","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib27","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3324\/haematol.2009.008474","article-title":"Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma","volume":"94","author":"Dictor","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib28","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2141.2008.07329.x","article-title":"The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival","volume":"143","author":"Wang","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1309\/R94MAFJY5EA4A8C3","article-title":"CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with","volume":"130","author":"Kelemen","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1309\/AJCPV8LN5ENMZOVY","article-title":"Immunophenotypic variations in mantle cell lymphoma","volume":"132","author":"Gao","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib33","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1182\/blood.V89.4.1421","article-title":"Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones","volume":"89","author":"Ott","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib34","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2007-10-117010","article-title":"Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group","volume":"111","author":"Determann","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib35","doi-asserted-by":"crossref","DOI":"10.1007\/s12308-009-0036-x","article-title":"Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network","author":"Klapper","year":"2009","journal-title":"J Hematopathol"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib36","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2011.03.006_bib37","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fernandez","year":"2010","journal-title":"Cancer Res"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196311000333?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196311000333?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:20:20Z","timestamp":1758522020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196311000333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0037196311000333"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2011.03.006","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathology of Mantle Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2011.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}